Advances in Dermatology and Allergology
eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current Issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2025
vol. 42
 
Share:
Share:
abstract:
Review paper

Methotrexate in the treatment of atopic dermatitis

Roman J. Nowicki
1, 2
,
Elżbieta Grubska-Suchanek
2
,
Aleksandra Wilkowska
2
,
Dmitrij F. Khvorik
3
,
Magdalena Trzeciak
1, 2

  1. Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, Poland
  2. Department of Dermatology, Venereology and Allergology, University Clinical Centre, Gdansk, Poland
  3. Department of Dermatovenereology, The Grodno State Medical University, Grodno, Belarus
Adv Dermatol Allergol 2025; XLII (3): 243-247
Online publish date: 2025/04/15
View full text Get citation
 
Atopic dermatitis (AD) is a common inflammatory skin disease. Most cases start in children although some have been reported in adults. Moderate to severe cases of AD not responding to topical treatments may need systemic therapy. Methotrexate may be considered in patients with severe AD who did not achieve the expected improvement after cyclosporine, or who had adverse effects and no possibility of biological treatment with monoclonal antibodies or Janus kinase inhibitors.
keywords:

atopic dermatitis, systemic therapy, methotrexate

Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.